Sinovac Biotech said on Saturday that its unit’s COVID-19 vaccine has been formally approved for use by the general public by China’s medical products regulator, according to Reuters.
It marks the second COVID-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.
Prior to the approvals, both vaccines have already been used in China’s vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release.
The approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained, Sinovac said.
Mexico gets China’s Sinovac vaccine paperwork for approvalMexico announced Friday that Sinovac, the Chinese manufacturer of the CoronaVac vaccine, has submitted paperwork for approval in Mexico. Another ... Coronavirus
Coronavirus: 6.5 mln doses of the Sinovac vaccine arrives in TurkeyA second consignment of 6.5 million doses of the coronavirus vaccine made by China’s Sinovac Biotech has arrived in Turkey, CNN Turk reported on ... Coronavirus
Coronavirus: China’s Sinovac vaccine faces driver shortage, says distributorA Chinese distributor of Sinovac’s COVID-19 vaccine said on Thursday it is facing a shortage of drivers, as the worst wave of new infections in almost ... Coronavirus